| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |